Tagged with P

Servier Poland Unlike many pharmaceutical companies, Servier fully operates in all pharma business activities in Poland: research, drug manufacturing and distribution, and health education. Considering your extensive international and regional experience in Romania, Russia, and Bulgaria, but also Vietnam, what is unique here? What is there in Poland that is attracting the…

Genzyme Poland With the current acquisition of Genzyme by Sanofi-Aventis, the French giant is planning to have Genzyme as a centre of excellence for rare diseases. Genzyme operates in the genetic market, in bio-surgery, in oncology, and also in transplant. What area has been driving the growth in 2010? In value terms,…

Torrex Chiesi Poland Would you begin by explaining to the readers of Pharmaceutical Executive the importance of the operation in Poland for the company? Indeed Poland because of largest in CEE pharmaceutical market size was always very attractive for all pharmaceutical companies, although it is a very complex market. For those coming to…

Quintiles Poland Firstly, what attracted you to join the CRO industry with Quintiles over 10 years ago? I had been working for 5 years as a doctor in the internal medicine and intensive care departments of the Warsaw medical school. The team there was already conducting some medical research in the clinic.…

Octapharma Brazil Mr. Mauricio, you’ve mentioned that Brazil is a different kind of market for Octapharma, one strongly based on price, and that because of this it’s hard to add value. Could you delve a bit deeper and elaborate on this point? Before delving into the Brazilian market situation, it is important…

BOIRON Czech Republic In the Czech Republic, homeopathic medicines were prohibited during the communistic period, but found resurgence after 1989. Can you give us an overview of the development of this form of treatment in the Czech market, and speak about the role that BOIRON has had in the evolution of the segment?…

Pharmaceutical Manufacturers Association of Turkey (IEIS) IEIS is an association with dual responsibilities. Promotion of generic usage in turkey and ensuring the sustained development of a local manufacturing industry. Before we look into these two aspects, I would like you to give us your perspective on the future role of the association, in an environment where…

Private Hospitals Association The Association was founded in 1984 and has played an important role throughout the decades improving the standards of the country’s private hospitals. How important is the Association today in building the success of the Jordanian private hospital industry? The Private Hospitals Association (PHA) is a private voluntary, non-profit organization…

Gelpharma Gelpharma started in 1999 and its main strength lies in manufacturing. Please can you give us a more detailed history of the company and its major milestones since opening? We started over forty years ago from a company called Vitae Laboratorios that for many years had two soft-gel products manufactured…

Grupo Ifaco The company Cryopharma was founded in 1954 with 10 employees. Today, you have fantastic facilities here in the state of Jalisco, and have grown the company to an entire group – Grupo IFACO – with more than 400 employees…Could you tell us about the major achievements and milestones of Grupo…

Asociace inovativního farmaceutického průmyslu (AIFP) Mr. Dvořáček, in 2010, the AIFP commissioned a study on the economic footprint of the innovative pharmaceutical industry in the Czech Republic. Can you begin by expounding the results of this study? The footprint of the innovative pharma industry in this market is not particularly large relative to other industries,…

Sdružení výrobců volně prodejných léčivých přípravků (SVOPL-OTC) Mr. Kotek, can you please begin by introducing us to the SVOPL and telling us what the mission is here in the Czech Republic? We are a relatively new Association that was founded only back in 2000. Before, we were a branch of a larger Association of international drug producers…